NHS Generic Pharmaceuticals - Wave 16c
NHS England
- Value
- £576,000,000
- Published
- 4 Sept 2026
- Deadline
- Not stated
- Procedure
- Open procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- UKC, United Kingdom
- Notice reference
- 083835-2026
Requirements summary
NHS England is planning an open-procedure framework procurement for Wave 16c NHS generic pharmaceuticals, covering oral products for the London South and North East (DLS & DNE) regions and housekeeping products for the remaining regions. The notice gives an estimated value of GBP 480m excluding VAT (GBP 576m gross), with a contract period from 1 June 2028 to 31 May 2030 and a maximum extent to 31 May 2032. Commencement and award are subject to budgetary approval.
Key requirements
- Supply of oral generic pharmaceutical products for the London South and North East (DLS & DNE) regions under Wave 16c
- Supply of housekeeping products for the remaining regions in scope, which the notice's delivery addresses list as all nine English regions
- Framework agreement with a contract period from 1 June 2028 to 31 May 2030, extendable to 31 May 2032 with a renewal option
- Estimated value of GBP 480m excluding VAT (GBP 576m gross)
- SME suitability indicated for the lot
- Planned procurement: procurement and award are subject to budgetary approval, and a future notice is expected by 6 September 2027